Boston Pharmaceuticals signs three-year agreement with GSK

Boston Pharmaceuticals signs three-year agreement with GSK

Source: 
Pharmaceutical Business Review
snippet: 

The US-based clinical stage biopharmaceutical company Boston Pharmaceuticals has announced the signing of a unique three-year out-license and option agreement with the UK-based GlaxoSmithKline (GSK).